Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Richard Apps

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Neurosurgical Focus|December 2, 2016
Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practiceJohn Richard Apps, Juan Pedro Martinez-Barbera
Neuro-Oncology|December 27, 2022
A promising future for hypothalamic dysfunction in craniopharyngiomaJohn Richard Apps, Juan Pedro Martinez-Barbera
Brain Pathology (Zurich, Switzerland)|April 18, 2017
Genetically engineered mouse models of craniopharyngioma: an opportunity for therapy development and understanding of tumor biologyJohn Richard Apps, Juan Pedro Martinez-Barbera
Best Practice & Research. Clinical Endocrinology & Metabolism|October 12, 2025
Decoding craniopharyngioma: From mechanisms to therapyJose Mario Gonzalez-Meljem, Lei Cao, John Richard Apps, et al.
British Journal of Cancer|April 20, 2018
Paracrine roles of cellular senescence in promoting tumourigenesisJose Mario Gonzalez-Meljem, John Richard Apps, Helen Christina Fraser, et al.
Endocrine Reviews|December 27, 2022
Contemporary Biological Insights and Clinical Management of CraniopharyngiomaJohn Richard Apps, Hermann Lothar Muller, Todd Cameron Hankinson, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Neurosurgical Focus|December 2, 2016
Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practiceJohn Richard Apps, Juan Pedro Martinez-Barbera
Neuro-Oncology|December 27, 2022
A promising future for hypothalamic dysfunction in craniopharyngiomaJohn Richard Apps, Juan Pedro Martinez-Barbera
Brain Pathology (Zurich, Switzerland)|April 18, 2017
Genetically engineered mouse models of craniopharyngioma: an opportunity for therapy development and understanding of tumor biologyJohn Richard Apps, Juan Pedro Martinez-Barbera
Best Practice & Research. Clinical Endocrinology & Metabolism|October 12, 2025
Decoding craniopharyngioma: From mechanisms to therapyJose Mario Gonzalez-Meljem, Lei Cao, John Richard Apps, et al.
British Journal of Cancer|April 20, 2018
Paracrine roles of cellular senescence in promoting tumourigenesisJose Mario Gonzalez-Meljem, John Richard Apps, Helen Christina Fraser, et al.
Endocrine Reviews|December 27, 2022
Contemporary Biological Insights and Clinical Management of CraniopharyngiomaJohn Richard Apps, Hermann Lothar Muller, Todd Cameron Hankinson, et al.
Pageof 1